Results of surgical treatment and postoperative adjuvant chemotherapy of renal pelvic and ureteral cancer by 沼沢, 和夫 et al.
Title腎盂尿管癌の外科的治療ならびに術後補助化学療法による治療成績
Author(s)沼沢, 和夫; 柿崎, 弘; 平野, 順治; 久保田, 洋子; 鈴木, 騏一;平野, 和彦; 鈴木, 仁









           化学療法による治療成績
山形大学医学部泌尿器科学教．室（主任；鈴木駿一教授）
沼沢 和夫，柿崎  弘，平野 順治
久保田洋子，鈴木 験一
山形県立新庄病院泌尿器科
平  野  和  彦．
山形県立河北病院泌尿器科
鈴  木     仁
RESULTS OF SURGICAL TREATMENT AND POSTOPERATIVE
      ADJUVANT CHEMOTHERAPY FOR RENAL PELVIC
                     AND URETERAL CANCER
    Kazuo NuMAsAwA， Hiroshi KAKizAKi， Junji HmANo，
            Yoko KuBoTA and Kiichi SuzuKi
llrom the DePartment 2ズ乙rrolog2， Yamagataこ113ゴひθγ5∫妙Scゐool（ゾルtediLi’ze
                   Kazuhiko HmANo
Fr・規磁DePartment・f Ur・Z・9ア． yαη・agat・Prefe・館αご8ゐ切・H・spit・Z
                     Hitoshi Suzum
From the Department ef Urologv， Yamagata Prefectural Kahoku HosPitat
   During the iO－year－and－9－month period from July 1977 to March 1988， 34 cases of renal pelvic
and ureteral cancer were surgically treated with total nephroureterectomy combined with partial
cystectomy． ln cases where the histopathological examination of the surgically excised specimen
disclosed a high stage， high grade cancer with vascular tumor invasion， postoperative adjuvant che－
motherapy was carried out using cisplatin， cytosine arabinoside and tegafur．
   Of the 34 cases， 22 are still alive， 7 （20．6％） died of cancer and 5 died of other causes．
Histopathologically， all of the 7 patients who died of cancer were found to have grade’ 3 and stage
p’1”2 or pT3 cancers with intravascular tumor invasion． Cisplatin was used in 13 of the 18 high
grade， high stage cases with intravascular tumor invasion． The’morta1ity due to cancer in these
13 cases was 30．8％， while 3 and 5－year survival rates were 69．2％ and 51．9％， respectively． ln the
remaining 5 cases in which cisplatin was not used for postoperative chemotherapy， the mortality
due to cancer was 60．0％ and the 3 and 5－year survival rates were 53．3％o and 26．7％， respective1y．
Thus， the patients who received postoperative chemotherapy tended to show a better survival rate
than those who did not， although the difference in the suuvival curves between the two groups
was not statistically significant．
   The results from the present study suggest the usefulness of postoperative adjuvant gherno－
therapy in high stage， high grade tenal pelvic and ureteral cancer with intravascular tumor invasion，
                                                  （Acta Urol． Jpn． 35： 1291－1298， 1989）














































cisplatin 50 mg／日週工回， cytosine arabinoside




     50mg／day
     静注
 Ara C 2emg／day
     静注
 Tegafur 800mg／day
     静注
or Tegafur 600mg／day
     経ロ
 Tegafur 750mg／day
     経直腸
 UFT 300mg／day
     経口
   Table 2．術後化学療法
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 Stage別の生存率ではstage pTa， pT1の3年生
存率は100％，5年生存率は33．3％であり，stage pT2
では3年70．OAo，5年46．7％， stage pT3， pT4では
Table 4．二二尿管癌のgrade， stage，脈管内侵
     襲所見別転帰
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生 存   6
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計 15 19 34
3年67．7％，5年54． 2％と各stage間に有意差は認
められなかった（Fig．4）．しかし同様に癌死につい
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はRubensteinら4）はstage A 60％， stage B 43
％，stage CO％， stage D O％と述べており，尿管
癌ではMillsら12）はstage A 80％， stage B 66・7
％，stage C 33．3％， Stage D l4％と報告し，腎孟
尿管癌ではAkazaら13）はpTa 101．3％， pT184・8




grade 1 100％， grade II 81thO ， grade III 29％，
Reite王rnanら15）はgrade I IOO％， II；87％， III；





I77％， II；58％、 III， IV；55％， grade 3ではstage
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